Click to Share
 

First Choice Neurology Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

13077519
By First Choice Neurology
The FDA cleared Fujirebio's Lumipulse Plasma Ratio blood test for the early detection of amyloid plaques associated with Alzheimer's disease (AD). Lumipulse is the first in-vitro diagnostic (IVD) test used in the diagnosis of AD.
13074429
By First Choice Neurology
First Choice Neurology is proud to announce a groundbreaking partnership with NeuroDiscovery AI (NDAI), a national leader in artificial intelligence, data analytics, and clinical dashboarding for neurology.
13072081
By First Choice Neurology
Neurologists working in a hospital-integrated setting experience an average income reduction of $9,652
13047990
By First Choice Neurology
Dementia Specialist, Dr. Jeffrey Gelblum, Expands the Infusion Center in his Jupiter Neurology Office.
13031133
By First Choice Neurology
Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.
13028887
By First Choice Neurology
First Choice Neurology, the largest neurology group in the United States, is set to make medical history next week as Dr. Jennifer Buczyner and Dr.
13015671
By First Choice Neurology
Visit First Choice Neurology at the AAN Annual Meeting, Booth 1643 on April 13-18 to learn about physician opportunities.
12988818
By First Choice Neurology
First Choice Neurology, the largest neurology group in the US, announced that it has been recognized by Modern Healthcare as one of the Top Innovators for 2023.
12979960
By First Choice Neurology
Dr. Jeffrey Gelblum, Senior Neurologist at First Choice Neurology educates patients about the risk of dementia and Alzheimer's disease.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share